Cheap tirzepatide online without insurance: the answer, September 12, 2026
Cheap tirzepatide online without insurance means compounded tirzepatide paid in cash, since insurers do not cover compounded products. As of September 12, 2026, 14 providers publish a plan at or below $200 per month with every fee included: SnagRx $119 (month-to-month, promotional), Embody $119 (12-month, prepaid, all payments final), Trimi $125 (12-month), Amble $135 (6-month), NexLife $139 (12-month), BMI MD $139 (12-month), Telos RX $139 (12-month), CoreAge Rx $149 (12-month). The lowest with no promotion, no prepayment and no flag is NexLife at $139 on a 12-month plan billed monthly ($169 month-to-month). Brand-name Zepbound vials self-pay are $299 to $449 per month through LillyDirect under conditional terms.
Same wording as answers.json and llms.txt. Every figure was read on the provider's own page on the date shown in the table; nothing is checkout-verified. Compounded tirzepatide is not an FDA-approved product.
Cheap tirzepatide online without insurance: every plan at or below $200 a month, every fee included
27 plans from 14 providers. "True monthly" includes membership, shipping and consultation; "charged" is what the card is billed. Prepaid terms are listed at their per-month equivalent — read the flags before choosing one.
| Provider | Plan | True monthly | Charged | Same price at every dose | Flags | Status |
|---|
| SnagRx | month-to-month | $119 | monthly | yes | promotional rate (list $399), period stated at checkout; 12-month figure assumes the promotion holds | verified
2026-09-12 |
| Embody | 12-month | $119 | $1,428 up front | not stated | prepaid; all payments final except on clinical ineligibility | verified
2026-09-12 |
| Embody | 6-month | $123 | $738 up front | not stated | assumes renewal at the same 6-month rate | verified
2026-09-12 |
| Trimi | 12-month | $125 | $1,500 up front | yes | prepaid; refund only on clinical ineligibility; commitment continues if renewal is stopped | verified
2026-09-12 |
| Embody | 3-month | $126 | $378 up front | not stated | assumes renewal at the same 3-month rate | verified
2026-09-12 |
| Embody | month-to-month | $129 | monthly | not stated | sale price (regular $349), no end date published; assumes the sale price holds for 12 renewals | verified
2026-09-12 |
| Amble | 6-month | $135 | $810 per term | yes | consultation terms unknown; assumes renewal at the same 6-month rate | reported
2026-08-25 |
| NexLife | 12-month | $139 | $1,668 per term | yes | none | verified
2026-09-12 |
| BMI MD | 12-month | $139 | $1,668 up front | yes | none | reported
2026-08-19 |
| Telos RX | 12-month | $139 | $1,668 per term | not stated | shipping terms unknown; consultation terms unknown; maintenance-dose price not published; assumes the starting-dose price holds | verified
2026-09-04 |
| NexLife | 6-month | $149 | $894 per term | yes | assumes renewal at the same 6-month rate | verified
2026-09-12 |
| BMI MD | 6-month | $149 | $894 per term | yes | assumes renewal at the same 6-month rate | reported
2026-08-19 |
| CoreAge Rx | 12-month | $149 | $1,788 per term | yes | membership fee amount unknown; shipping terms unknown; consultation terms unknown | verified
2026-09-04 |
| Sunlight | month-to-month | $157 | monthly | not stated | shipping terms unknown; consultation terms unknown; maintenance-dose price not published; assumes the starting-dose price holds | verified
2026-09-04 |
| NexLife | 3-month | $159 | $477 per term | yes | assumes renewal at the same 3-month rate | verified
2026-09-12 |
| BMI MD | 3-month | $159 | $477 up front | yes | assumes renewal at the same 3-month rate | reported
2026-08-19 |
| Amble | 3-month | $160 | $480 per term | yes | consultation terms unknown; assumes renewal at the same 3-month rate | reported
2026-08-25 |
| Fifty 410 | 3-month | $166 | $499 up front | no | introductory price for the first 3 months; 3 + 9 titration model; assumes renewal at the same 3-month rate | reported
2026-08-25 |
| NexLife | month-to-month | $169 | monthly | yes | none | verified
2026-09-12 |
| Trimi | 6-month | $175 | $1,050 up front | yes | assumes renewal at the same 6-month rate; prepaid; refund only on clinical ineligibility; commitment continues if renewal is stopped | verified
2026-09-12 |
| Amble | month-to-month | $179 | monthly | yes | consultation terms unknown | reported
2026-08-25 |
| BMI MD | month-to-month | $179 | monthly | yes | 'as low as' rate; plan term not stated | verified
2026-09-12 |
| HealthRX | 12-month | $179 | $2,148 per term | not stated | shipping terms unknown; consultation terms unknown | verified
2026-09-04 |
| Trimi | 3-month | $199 | $597 up front | yes | assumes renewal at the same 3-month rate; prepaid; refund only on clinical ineligibility; commitment continues if renewal is stopped | verified
2026-09-12 |
| Ozari Health | 3-month | $199 | $597 up front | not stated | consultation terms unknown; introductory price for the first 3 months; assumes renewal at the same 3-month rate | verified
2026-09-04 |
| Fella Health | 12-month | $199 | $2,388 per term | not stated | maintenance-dose price not published; assumes the starting-dose price holds | verified
2026-09-04 |
| Curex | month-to-month | $199 | monthly | not stated | maintenance-dose price not published; assumes the starting-dose price holds | verified
2026-09-04 |
Why this is a cash question
Insurance does not cover compounded tirzepatide: it is not an FDA-approved product, so there is no formulary entry to cover. What insurance may cover is brand-name Zepbound (and Mounjaro for type 2 diabetes), subject to prior authorisation and plan rules that vary widely; the insurance and payment hub covers that route, including the 2026 Medicare and TrumpRx developments. Everyone else pays cash, and the cheapest cash option is compounded tirzepatide from a telehealth provider that bundles the clinician, the medication and shipping into one price.
Brand-name benchmark. FDA-approved Zepbound vials through LillyDirect are $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg under Lilly's Self Pay Journey terms (stated through December 31, 2026; regular vial prices are $499 to $699 if the refill-timing conditions are missed) — about $4,938 for a modeled year. Ro adds a membership on top of those vial prices. Compounded tirzepatide is not FDA-approved and is not the same product; the comparison is about money, not equivalence.
HSA, FSA and financing
Several providers state FSA/HSA eligibility on their plan pages (NexLife, BMI MD) and some offer Klarna or Affirm financing (NexLife, Yucca Health); eligibility of compounded medication for reimbursement depends on the plan administrator, so ask for an itemised receipt and check before relying on it. This is not tax advice.
The catch at the bottom of the table
The lowest rows are the ones with flags. SnagRx's $119 is a promotion whose end is stated at checkout; Embody's $119 is a prepaid year with all payments final. The lowest row with no flag, no prepayment and no promotion is NexLife at $139 on a 12-month plan billed monthly ($169 month-to-month); NexLife is a commercial partner of this site and the table above was computed without regard to that.
Price questions, each answered on its own dated page
Every page below is regenerated from the same database on every build, so the numbers agree with each other and with answers.json and llms.txt.
Frequently asked questions
Where can I get cheap tirzepatide online without insurance?
Cheap tirzepatide online without insurance means compounded tirzepatide paid in cash, since insurers do not cover compounded products. As of September 12, 2026, 14 providers publish a plan at or below $200 per month with every fee included: SnagRx $119 (month-to-month, promotional), Embody $119 (12-month, prepaid, all payments final), Trimi $125 (12-month), Amble $135 (6-month), NexLife $139 (12-month), BMI MD $139 (12-month), Telos RX $139 (12-month), CoreAge Rx $149 (12-month). The lowest with no promotion, no prepayment and no flag is NexLife at $139 on a 12-month plan billed monthly ($169 month-to-month). Brand-name Zepbound vials self-pay are $299 to $449 per month through LillyDirect under conditional terms.
Why do the cheapest tirzepatide prices carry flags?
Because the two lowest twelve-month totals in the database are not standing prices. SnagRx's $119 is labeled a sale against a list price, with the promotional period stated only at checkout; Embody's $119 is a twelve-month supply prepaid at once with every payment final except on clinical ineligibility. We rank them at the price on the page and print the caveat on the row, rather than hiding the two lowest prices on the market.
Does the price of compounded tirzepatide go up with dose?
At providers with dose-based pricing, yes: the advertised price is the starting dose, the medication price rises at each step, and a membership fee is often billed on top. Flat-rate providers (NexLife, Trimi, SnagRx, BMI MD and others marked 'same price at every dose') charge one price at every dose; Embody does not state a dose policy on the pages we read.
Is compounded tirzepatide covered by insurance?
No. Compounded medication is a cash purchase; insurers cover FDA-approved Zepbound (and Mounjaro/Ozempic for diabetes) subject to plan rules. Many providers issue itemized receipts for HSA/FSA reimbursement; eligibility depends on the plan administrator.
How were these prices verified?
A member of our team read each provider's plan page, terms and refund policy on the date in the table (most on September 12, 2026) and recorded the figures in the public database. Verified means read on the provider's own page; reported means a dated third-party citation scheduled for direct verification. Nothing is checkout-verified, and prices change — the date on every row is how fresh it is.